ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI)

CUSIP: 774374300

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class
Equity / Common Stock, par value $0.0001 per share
Total 13F shares
5,890,963
Total 13F value
$4,995,180
Holder snapshot 6 visible 7 signals
Share change
-1,074,592
Put/Call ratio
8.1%
SEC-reported price per share
$0.85
Number of holders
42
Value change
-$990,478
Number of buys
14
Open additional details 1 more signal available
Number of sells
22
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
89,116,466

Security key

774374300

Report period

Q2 2025

Institutions

42

Top holders

10

RMTI full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 ROCKWELL MEDICAL, INC. SEC filings ROCKWELL MEDICAL, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Irrevocable Larson Family...
Disclosed value leader
Irrevocable Larson Family...
Comparable rows
15/15
Latest evidence
20 May 2025
3/4/5 13D/G 13F Lead comparable stake: 11% 13D/G row: Irrevocable Larson Family Investment Trust Showing 1-6 of 15 holder rows.

Quick read

Irrevocable Larson Family Investment Trust leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Irrevocable Larson Family Investment Trust's linked filing trail.
Comparable ownership Top 5
Irrevocable Larson Family Investm... 11%
Mark H. Ravich 0.17%
Andrea Heslin Smiley 0.16%
ARMISTICE CAPITAL, LLC 2.7%
VANGUARD GROUP INC 1.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Irrevocable Larson Family Investment Trust
3/4/5 13D/G
10%+ Owner
3/4/5 13D/G
11%
from 13D/G
$3,861,311
3,557,500 shares
 — 10 Apr 2025
Mark H. Ravich
3/4/5
Director
3/4/5
0.17%
$149,590
151,103 shares
 — 20 May 2025
Andrea Heslin Smiley
3/4/5
Director
3/4/5
0.16%
$140,641
142,062 shares
 — 20 May 2025
ARMISTICE CAPITAL, LLC
13F
Company
13F
2.7%
$2,673,743
2,366,144 shares
 — 31 Mar 2025
VANGUARD GROUP INC
13F
Company
13F
1.4%
$1,362,113
1,205,410 shares
 — 31 Mar 2025
GLOBEFLEX CAPITAL L P
13F
Company
13F
0.83%
$839,879
743,256 shares
 — 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
42
Shares
5,890,963
Rows available
42
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
46
Q2 2025 holders
42
Holder diff
-4
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .